Trends and predictors of resection of the primary tumor for patients with stage IV colorectal cancer

Journal of Surgical Oncology

Volumn 111, Issue 7, 2015, Pages 911-916

  Shapiro, Mia ^a   Rashid, Naim U ^b   Whang, Edward E ^a,c   Boosalis, Valia A ^a,d   Huang, Qin ^a   Yoon, Charles ^a,c   Saund, Mandeep S ^a,e,f   Gold, Jason S ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

metastatic colorectal cancer; primary tumor resection; SEER

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; COLON RESECTION; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; RECTUM RESECTION; TUMOR VOLUME; ADENOCARCINOMA; CANCER GRADING; CANCER REGISTRY; COLORECTAL NEOPLASMS; FOLLOW UP; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PATHOLOGY; PROGNOSIS; SECONDARY;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASMS, MULTIPLE PRIMARY; PROGNOSIS; SEER PROGRAM;

EID: 84928827922     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23906     Document Type: Article

References (34)

1. Tan KK, Lopes Gde L, Jr., Sim R,: How uncommon are isolated lung metastases in colorectal cancer? A review from database of 754 patients over 4 years. J Gastrointest Surg 2009; 13: 642-648.
2. Fortner JG, Silva JS, Golbey RB, et al.: Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 1984; 199: 306-316.
3. Ballantyne GH, Quin J,: Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 1993; 71: 4252-4266.
4. Leporrier J, Maurel J, Chiche L, et al.: A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 2006; 93: 465-474.
5. Ruo L, Gougoutas C, Paty PB, et al.: Elective bowel resection for incurable stage IV colorectal cancer: Prognostic variables for asymptomatic patients. J Am Coll Surg 2003; 196: 722-728.
6. Ferrand F, Malka D, Bourredjem A, et al.: Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Federation Francophone de Cancerologie Digestive 9601. Eur J Cancer 2013; 49: 90-97.
7. Cirocchi R, Trastulli S, Abraha I, et al.: Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cochrane Database Syst Rev 2012; 8: CD008997.
8. Nitzkorski JR, Farma JM, Watson JC, et al.: Outcome and natural history of patients with stage IV colorectal cancer receiving chemotherapy without primary tumor resection. Ann Surg Oncol 2012; 19: 379-383.
9. Poultsides GA, Servais EL, Saltz LB, et al.: Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 2009; 27: 3379-3384.
10. McCahill LE, Yothers G, Sharif S, et al.: Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10. J Clin Oncol 2012; 30: 3223-3228.
11. Tebbutt NC, Norman AR, Cunningham D, et al.: Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 2003; 52: 568-573.
12. Seo GJ, Park JW, Yoo SB, et al.: Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage IV colorectal cancer. J Surg Oncol 2010; 102: 94-99.
13. Van Cutsem E, Cervantes A, Nordlinger B, et al.: Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014; 25:Suppl 3 iii1-9.
14. Benson AB, 3rd, Bekaii-Saab T, Chan E, et al.: Metastatic colon cancer, version 3.2013: Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 2013; 11: 141-152; quiz 152.
15. Chang GJ, Kaiser AM, Mills S, et al.: Practice parameters for the management of colon cancer. Dis Colon Rectum 2012; 55: 831-843.
16. NCCN Practice Guildelines in Oncology. In: Colon cancer. http://www.nccn.org: http://www.nccn.org
17. NCCN Practice Guidelines in Oncology. In: Rectal cancer. http://www.nccn.org: http://www.nccn.org
18. Temple LK, Hsieh L, Wong WD, et al.: Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol 2004; 22: 3475-3484.
19. Cook AD, Single R, McCahill LE,: Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 2005; 12: 637-645.
20. Scheer MG, Sloots CE, van der Wilt GJ, et al.: Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol 2008; 19: 1829-1835.
21. Meissner HI, Breen N, Klabunde CN, et al.: Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006; 15: 389-394.
22. Paulson EC, Wirtalla C, Armstrong K, et al.: Gender influences treatment and survival in colorectal cancer surgery. Dis Colon Rectum 2009; 52: 1982-1991.
23. Ahmed S, Howel D, Debrah S,: Norccag: The influence of age on the outcome of treatment of elderly patients with colorectal cancer. J Geriatr Oncol 2014; 5: 133-140.
24. Wang L, Wilson SE, Stewart DB, et al.: Marital status and colon cancer outcomes in US Surveillance, Epidemiology and End Results registries: Does marriage affect cancer survival by gender and stage? Cancer Epidemiol 2011; 35: 417-422.
25. Robbins AS, Pavluck AL, Fedewa SA, et al.: Insurance status, comorbidity level, and survival among colorectal cancer patients age 18-64 years in the National Cancer Data Base from 2003 to 2005. J Clin Oncol 2009; 27: 3627-3633.
26. Parikh AA, Robinson J, Zaydfudim VM, et al.: The effect of health insurance status on the treatment and outcomes of patients with colorectal cancer. J Surg Oncol 2014; 110: 227-232.
27. Munene G, Parker RD, Shaheen AA, et al.: Disparities in the surgical treatment of colorectal liver metastases. J Natl Med Assoc 2013; 105: 128-137.
28. Cooper GS, Yuan Z, Landefeld CS, et al.: Surgery for colorectal cancer: Race-related differences in rates and survival among Medicare beneficiaries. Am J Public Health 1996; 86: 582-586.
29. Aizer AA, Wilhite TJ, Chen MH, et al.: Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer 2014; 120: 1532-1539.
30. Birkmeyer JD, Reames BN, McCulloch P, et al.: Understanding of regional variation in the use of surgery. The Lancet 2013; 382: 1121-1129.
31. Thirunavukarasu P, Sukumar S, Sathaiah M, et al.: C-stage in colon cancer: implications of carcinoembryonic antigen biomarker in staging, prognosis, and management. J Natl Cancer Inst 2011; 103: 689-697.
32. Park YJ, Park KJ, Park JG, et al.: Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg 1999; 23: 721-726.
33. Rahbari NN, Lordick F, Fink C, et al.: Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS-a randomised controlled multicentre trial (ISRCTN30964555). BMC Cancer 2012; 12: 142.
34. 't Lam-Boer J, Mol L, Verhoef C, et al.: The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer-a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG). BMC Cancer 2014; 14: 741.